Accelerating cancer research through comprehensive genomic analysis
- Home
- Accelerating cancer research through comprehensive genomic analysis
![](https://a.storyblok.com/f/196663/2069x2078/2dec7bda5c/cancer-white-paper-2-pages.png/m/800x0/filters:format(webp))
Overview
In this white paper, you will learn how cancer researchers are using nanopore sequencing to overcome the key challenges associated with short-read sequencing technologies to deliver:
- More complete and contiguous cancer genome assemblies
- Accurate resolution of structural variants and repeat regions
- Rapid identification of fusion genes and full-length transcript isoforms
- Detection of low-abundance cell-free DNA (cfDNA) and circulating tumour DNA (ctDNA)
- Streamlined sequencing of targeted regions
- Detection of epigenetic base modifications from native DNA/RNA — no additional sample prep or sequencing runs required
Read customer case studies describing the detection of a wide variety of genomic variants across a wide range of cancers, including cervical cancer, colorectal cancer, acute myeloid leukaemia, and organoids.